BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26796800)

  • 1. [Inhibitory effect of a Chinese medicine Xiaoaiping combined with cisplatin on the proliferation, invasion and apoptosis in ovarian cancer HO-8910 PM cells in vitro and in vivo].
    Zheng A; Li T; Chen Y; Fang J; Zhang Y; Feng J
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):11-6. PubMed ID: 26796800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xiaoaiping combined with cisplatin can inhibit proliferation and invasion and induce cell cycle arrest and apoptosis in human ovarian cancer cell lines.
    Zheng AW; Chen YQ; Fang J; Zhang YL; Jia DD
    Biomed Pharmacother; 2017 May; 89():1172-1177. PubMed ID: 28320083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xiaoaiping injection enhances paclitaxel efficacy in ovarian cancer via pregnane X receptor and its downstream molecules.
    Zhang XQ; Ding YW; Chen JJ; Xiao X; Zhang W; Zhou L; Kong QW; Shi MZ; Yang J; Jiang B; Guo C; Han YL
    J Ethnopharmacol; 2020 Oct; 261():113067. PubMed ID: 32505840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the effect of resveratrol on metastasis-associated ability of ovarian carcinoma HO-8910PM cells in vitro].
    Qin YM; Li K; He TP; Mo LE; Liang NC
    Zhong Yao Cai; 2007 Feb; 30(2):176-8. PubMed ID: 17571767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion.
    Wang H; Luo Y; Qiao T; Wu Z; Huang Z
    J Ovarian Res; 2018 Nov; 11(1):93. PubMed ID: 30454003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
    Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
    Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of cantharidin on invasion and metastasis of highly metastatic ovarian carcinoma cell line HO-8910PM].
    He TP; Mo LE; Liang NC
    Ai Zheng; 2005 Apr; 24(4):443-7. PubMed ID: 15820067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
    Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
    Wan J; Shi F; Xu Z; Zhao M
    Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
    Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
    Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Study on the Effect and Mechanism of Xiaoaiping (XAP) Injection and S-1 Combination Therapy in Inhibiting the Invasion and Metastasis of Human GC Cells.
    Wen P; Wang H; Ni T; Dai X; Chu Z; Ma S; Xiang L; Zhou Z; Qian Y; Sunagawa M; Liu Y
    Anticancer Agents Med Chem; 2021; 21(8):1037-1046. PubMed ID: 32951585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer.
    Ghosh S; Maity P
    J Environ Pathol Toxicol Oncol; 2010; 29(1):17-30. PubMed ID: 20528744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of recombinant human interleukin-24 alone and in combination with cisplatin on the growth of ovarian cancer cells in vitro].
    Wang S; Guo J; Tang Y; Zheng R; Song M; Sun W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):33-6. PubMed ID: 24405596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells.
    Leng Y; Zhao C; Yan G; Xu S; Yang Y; Gong T; Li X; Li C
    J Ovarian Res; 2021 Nov; 14(1):162. PubMed ID: 34789301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
    Shen W; Liang B; Yin J; Li X; Cheng J
    Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulative effect of genistein on xenografted tumor of ovarian carcinoma cell on nude mice].
    Wang X; Xin XY; Huang YH
    Zhongguo Zhong Yao Za Zhi; 2006 Jun; 31(11):901-4. PubMed ID: 17048629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells.
    Liu L; Fan J; Ai G; Liu J; Luo N; Li C; Cheng Z
    Biol Res; 2019 Jul; 52(1):37. PubMed ID: 31319879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.